A β‐Lactamase Responsive Peptide Inhibits MRSA Infection through Self‐Assembled Nanonet
Advanced Healthcare Materials · 2024-12 · 13 (31)
DOI: 10.1002/adhm.202402453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 09.08.2024. Verfasst von Minghao Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, beta-Lactamases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Shanghai Pujiang Program, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Gram‐positive S. aureus is one of the leading pathogens for death associated with antimicrobial resistance. The β‐lactamase (Bla) secreted by methicillin‐resistant S. aureus (MRSA) hydrolyzes nearly all β‐lactam antibiotics, leaving only a few antibiotics available for the clinical treatment of MRSA infections. Thereby, a Bla‐responsive peptide (BLAP) is designed here with the capacity of inhibiting MRSA infection through mimicking the host defense mechanism of human defensin‐6. The BLAP comprising a self‐assembling peptide sequence can respond specifically to the secreted Bla and assemble in situ surrounding MRSA. The assembled nanofibrous network is able to trap MRSA, preventing its invasion into the host cells effectively. As a consequence, the intramuscular injection of BLAP significantly restricted bacterial infection and abscess formation in mice. The biomimetic BLAP holds great potential for the efficient treatment of drug‐resistant gram‐positive bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
- School of Medicine, Shanghai University, Shanghai, 200444, China.
- Shanghai Engineering Research Center of Organ Repair, Shanghai, 200444, China.
- Shanghai Integration and Innovation Center of Marine Medical Engineering, Shanghai, 200444, China.
ORCID-Profile: Yejiao Shi, Honggang Hu
Förderung
- Shanghai Pujiang Program
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Wu, M., Li, Y., Shen, H., Zhang, Y., Cong, W., Hu, X., Shi, Y., & Hu, H. (2024). A β‐Lactamase Responsive Peptide Inhibits MRSA Infection through Self‐Assembled Nanonet. Advanced Healthcare Materials, 13(31). https://doi.org/10.1002/adhm.202402453
Vancouver
Wu M, Li Y, Shen H, Zhang Y, Cong W, Hu X, et al. A β‐Lactamase Responsive Peptide Inhibits MRSA Infection through Self‐Assembled Nanonet. Advanced Healthcare Materials. 2024;13(31). doi:10.1002/adhm.202402453
BibTeX
@article{Wu2024,
author = {Wu, Minghao and Li, Yuting and Shen, Huaxing and Zhang, Yanan and Cong, Wei and Hu, Xiaochun and Shi, Yejiao and Hu, Honggang},
title = {A β‐Lactamase Responsive Peptide Inhibits MRSA Infection through Self‐Assembled Nanonet},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {31},
doi = {10.1002/adhm.202402453}
}
EUVIMED